Skip to main content

Closed

NNVC: NanoViricides, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+0.0% / yr

Operating margin0.0%

ROIC-89.3%

Financially safe

Stretched

Debt / equity0.00×

Interest coverage0.0×

Current ratio3.17×

NanoViricides, Inc.

NNVCNew York Stock Exchange Arca·USD·Closed

NanoViricides, Inc.

NNVCNew York Stock Exchange Arca·USD·Closed

$1.52

−1.94%

$1.52

−$0.03 (1.94%)

52W Range

49thpctl

Volume

0.32×avg

Mkt Cap

38.61MUSD

P/E

-3.6TTM

Div Yield

–ann

52W Range

49thpctl

Volume

0.32×avg

Market Cap

38.61MUSD

P/E Ratio

-3.6TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings